The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After Pregnancy

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

April 15, 2027

Study Completion Date

April 15, 2028

Conditions
Gestational Diabetes Mellitus (GDM)Postpartum WomenUncomplicated Pregnancy
Interventions
DRUG

Intradermal Microdialysis

A total of three microdialysis sites will be perfused with ringer's solution, L-NAME, or ketorolac (one drug per site). After a baseline period, all three sites will undergo tests of blood vessel function including an acetylcholine dose-response protocol and a test of maximal skin blood flow with sodium nitroprusside.

OTHER

Brain Blood Flow Tests

Participants will complete CO2 breathing procedures to evaluate brain blood vessel health.

OTHER

Local Heating

A dime-sized heater will be placed on the skin to evaluate cutaneous microvascular function

All Listed Sponsors
lead

Anna Stanhewicz, PhD

OTHER